Hiperhomocisteinemia y preeclampsia

1998, Documentos de Consenso de la Sociedad Española de Ginecolgía y Obstetricia, 3, 45 Boushey, 1995, A quantitative assesment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, Jama, 274, 1049, 10.1001/jama.1995.03530130055028 Refsum, 1998, Homocysteine and cardiovascular disease, Ann Rev Med, 49, 31, 10.1146/annurev.med.49.1.31 Ommen, 1998, Preventing coronary heart disease: B vitamins and homocysteine, Circulation, 97, 421, 10.1161/01.CIR.97.5.421 Wald, 1998, Homocysteine and ischemic heart disease, Arch Int Med, 158, 862, 10.1001/archinte.158.8.862 Rajkovic, 1997, Elevated homocysteine levels with preeclampsia, Obstet Gynecol, 90, 168, 10.1016/S0029-7844(97)00223-8 Sánchez, 2001, Plasma folate, vitamin B (12), and homocysteine concentrations in preeclamptic and normotensive Peruvian women, Am J Epidemiol, 153, 474, 10.1093/aje/153.5.474 Lachmeijer, 2001, Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia, Am J Obstet Gynecol, 184, 394, 10.1067/mob.2001.109393 Ray, 1999, Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: A systematic review, Placenta, 20, 519, 10.1053/plac.1999.0417 Raijmakers, 2001, Oxidized and free whole blood thiol in preeclampsia, Obstet Gynecol, 97, 272, 10.1016/S0029-7844(00)01127-3 Perales, 2001, Niveles de ácido fólico, homocisteína y polimorfismo de la enzima metilentetrahidrofolatorreductasa (MTHFR) en pacientes con preeclampsia severa y eclampsia, Ginecol Obstet Mex, 1, 696 Raijmakers, 2000, Plasma thiols status in preeclampsia, Obstet Gynecol, 95, 180, 10.1016/S0029-7844(99)00514-1 Wang, 2000, Elevated circulating homocysteine levels in placental vascular disease and associated preeclampsia, Bjog, 107, 935, 10.1111/j.1471-0528.2000.tb11095.x Laivuori, 1999, Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia, Obstet Gynecol, 93, 489, 10.1016/S0029-7844(98)00527-4 Powers, 1998, Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation, Am J Obstet Gynecol, 179, 1605, 10.1016/S0002-9378(98)70033-X Raijmakers, 2001, Hyperhomocisteinaemia: a risk factor for preeclampsia?, Eur J Obstet Gynecol Reprod Biol, 95, 226, 10.1016/S0301-2115(00)00497-8 Kaiser, 2001, C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for preeclampsia/eclampsia among Australian women, Hum Hered, 51, 20, 10.1159/000022954 Mayerhofer, 2000, Serum homocysteine levels in women with preeclampsia, Wien Klin Wochenschr, 112, 271 Anderson, 1992, Decreased serum homocysteine in pregnancy, Eur J Clin Chem Clin Biochem, 30, 377 Hietala, 2001, Serum homocysteine at 16 weeks and subsequent preeclampsia, Obstet Gynecol, 97, 527, 10.1016/S0029-7844(00)01197-2 Hogg, 2000, Second-trimester plasma homocysteine levels and pregnancy induced hypertension, Am J Obstet Gynecol, 183, 805, 10.1067/mob.2000.109044 Sorensen, 1999, Elevated second-trimester serum homocysteine levels and subsequent risk of preeclampsia, Gynecol Obstet Invest, 48, 98, 10.1159/000010148 Kang, 1986, Total homocysteine in plasma and amniotic fluid of pregnant woman, Metabolism, 35, 889, 10.1016/0026-0495(86)90049-1 Fernández-Miranda, 1999, La hiperhomocisteinemia es frecuente en pacientes con enfermedad coronaria. Estudio de 202 enfermos, Med Clin, 113, 407